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Summary We have investigated the occurrence of attenuated extracolonic manifestations (AEMs) of familial
adenomatous polyposis (FAP) in patients with non-polyposis colorectal cancer. In a prospective case-control
study, we observed that significantly more colorectal cancer patients exhibited AEM than did age and sex-
matched controls (19.5% vs 7.5%, P<0.004). However patients with AEMs do not have occult FAP, as we
found no heterozygous adenomatous polyposis coli (APC) gene mutations despite extensive analysis of
constitutional DNA. Genome-wide DNA replication errors (RERs) occur in a proportion ofcolorectal cancers,
particularly right-sided lesions and in almost all tumours from hereditary non-polyposis colorectal cancer
(HNPCC) patients. As AEMs have been reported in familial colon cancer cases, we investigated the
relationship of AEMs to tumour RER phenotype. There was indeed an excess of AEMs in patients with right-
sided tumours (30.2% of 53 patients vs 14.7% of 116 patients, P<0.03) and in those with RER tumours (3 out
of 12 patients with RER tumours vs none out of 21 patients with non-RER tumours, P<0.05). Two patients
with AEM were from HNPCC families compared with none of those without AEM (P< 0.05). The association
of AEMs with colorectal cancer is intriguing, and we speculate that it may be a manifestation of mutational
mosaicism of the APC gene, perhaps associated with a constitutional defect in DNA mismatch pair.
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An association has been reported between sporadic colorectal
cancer and two clinical features that are normally considered
to be extracolonic manifestations of the autosomal dominant
syndrome familial adenomatous polyposis (FAP) (Sonder-
gaard et al., 1993; 1985a, b; Houlston et al., 1992; Dunlop,
1983; Hunt et al., 1994). These features, congenital
hypertrophy of the retinal pigment epithelium (CHRPE)
and mandibular osteomas, occur in 90% and 75%
respectively of patients with classical FAP (Utsunomiya and
Nakamura, 1975; Bulow et al., 1984; Traboulsi et al., 1987;
Berk et al., 1988; Chapman et al., 1989; Giardiello et al.,
1991; Hodgson et al., 1994; Wallis et al., 1994). The finding
of such extracolonic features in patients with non-FAP
colorectal cancer is of considerable interest because of the
central, and probably initiating, role of the gene for FAP
(APC) in colorectal tumorigenesis. Constitutional and
heterozygous mutation of the APC gene is responsible for
the FAP syndrome (Groden et al., 1991; Nishishio et al.,
1991; Nagase and Nakamura, 1993), while a high proportion
of non-FAP colorectal adenomas and cancers have somatic
APC mutations (Powell et al., 1992; Ichii et al., 1993;
Nagasse and Nakamura, 1993). Inactivating APC mutations
have also been noted in dysplastic aberrant crypt foci (Jen et
al., 1994; Smith et al., 1984), which are believed to be the
very earliest histological manifestation of colorectal neopla-
sia.
The available data suggest that the extracolonic manifesta-
tions of FAP, which we term attenuated extracholonic
manifestations (AEMs), occur particularly in colorectal
cancer patients with a family history of the disease
(Sondergaard et al., 1985b; Houlston et al., 1992; Hunt et
al., 1994). Thus we wished to determine whether there was
any link with hereditary non-polyposis colorectal cancer
(HNPCC), which is responsible for 2-5% of all colorectal
cancer cases. HNPCC gene carriers develop few colorectal
adenomas but are at high risk of colorectal cancer,
particularly of the right colon, as well as other cancers
(Lynch et al., 1993; Jass et al., 1994). Causative germline
mutations in the DNA mismatch repair (MMR) genes
hMSH2, hMLHI, hPMSJ and hPMS2 (Liu et al., 1996)
have been identified in HNPCC families. Such mutations
result in defective MMR (Parsons et al., 1993; Umar et al.,
1994), manifest as instability of repetitive DNA in tumours
(Ionov et al., 1993; Aaltonen et al., 1993; Thibodeau et al.,
1993; Peltomaki et al., 1993; Lothe et al., 1993; Aaltonen et
al., 1994; Bhattacharyya et al., 1994; Liu et al., 1995a) and
termed replication error (RER) tumour phenotype. Somatic
mutations in GTBP, another MMR gene, are responsible for
the RER phenotype in some tumours (Drummond et al.,
1995; Palombo et al., 1995; Papadopolous et al., 1995).
However, germline GTBP mutations have not been identified
in any of the highly penetrant HNPCC families analysed so
far (Papadopoulos et al., 1995), although GTBP involvement
in low-penetrance colorectal cancer susceptibility has not
been excluded. The RER tumour phenotype is present in
about 15% of sporadic colorectal cancers (Ionov et al., 1993;
Aaltonen et al., 1993;Thidodeau et al., 1993; Lothe et al.,
1993; Liu et al., 1995a), 80-90% of which are in the
proximal colon (Ionov et al., 1993; Thibodeau et al., 1993;
Lothe et al., 1993).
We have investigated the prevalance of AEMs in a
prospective case -control study. In order to elucidate the
underlying basis of this association, we evaluated AEM in
relation to tumour location, family history and tumour RER
phenotype to ascertain any link with MMR deficiency and
HNPCC. As we have excluded the possibility of unrecognised
cases of FAP by extensive APC gene mutation analysis, our
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observations are consistent with the hypothesis that AEMs
are a manifestation of mutation mosaicism of the APC gene
and may indicate genetically determined cases in a population
of sporadic colorectal cancer patients.
Methods
Study population and pedigree ascertainment
In order to obtain an unselected patient population group,
we enrolled 169 patients prospectively after surgery for
colorectal cancer in four Lothian hospitals. The four
hospitals together serve the entire population of Lothian
and admit essentially all patients in the region with colorectal
cancer on an emergency and elective basis. Thus, the study
population should be reasonably free of bias. Known FAP
cases or patients with colonic multiple polyposis were
excluded. Paired age and sex-matched healthy community
controls with no personal cancer history were enrolled from
patients registered with local Edinburgh medical practices
that refer patients to three of the same four hospitals from
which the cancer patients were recruited. Family histories
were documented in a standard proforma and verified from
statutory Scottish General Register Office records for first-
and second-degree relatives with cause of death, where
appropriate. Disease status for live relatives in Scottish
kindreds and members of families resident outside Scotland
was verified from clinical or pathology records. All personal
data, family history and retinal and mandible findings
together with data on tumour histology, staging and site
were collated in a computer database. Local ethics committee
approval was granted for all aspects of this study, including
mandibular radiography, ophthalmoscopy with mydriasis and
blood sampling.
Retinal and mandible examinations
Bilateral retinal examination was performed in 167 of the
patients and 160 of the controls described above by indirect
ophthalmoscopy (Model Omega 100, Heine, Germany), using
a Nikon 20D lens after mydriasis by one of two
opthalmologists. All efforts were made to ensure that the
ophthalomologists were unaware ofthe subjects' health status
and did not discuss recent operations or family history with
the patients. Retinal lesions were documented on fundal
charts and photographed. Thirty patients (with and without
CHRPE) were assessed by both ophthalomologists, and this
ensured inter-observer reproducibility. The diagnostic criteria
we used for retinal pigmentation in non-polyposis colorectal
cancer patients were the same as those taken as diagnostic of
CHRPE in familial adenomatous polyposis, namely: > 1
pigmented lesions with depigmented halo; >1 pigmented
lesions over one optic disc diameter; >3 small bilateral
pigmented lesions without a halo or >4 small unilateral
lesions (Traboulsi et al., 1987; Chapman et al., 1988; Berk et
al., 1988; Giardello et al., 1991; Hodgson et al., 1994; Wallis
et al., 1994). Because of the variety of CHRPE lesions, we
devised a scoring system derived from the relative importance
ascribed to each feature in previous FAP studies. Pigmented
haloed lesions and lesions > 1 disc diameter scored 5: small
lesions scored 1 and the total score for bilateral lesions was
doubted.
Posteroanterior, occlusal and pantomographic radio-
graphic views of the mandible were obtained using Roentgen
501, Siemens Heliodent MD and Morita Panex EC machines
respectively on 163 patients and 159 controls, with immediate
reveiw and further oblique or intra-oral views for incon-
clusive cases. Radiographs were interpreted independently on
two separate occassions by a radiologist and an oral surgeon
blinded to the subjects' disease status. Osteomas were defined
as discrete homogeneous radio-opaque areas >2 mm in
diameter- with no surrounding radiolucent zone, distinct
from the teeth and apices (Bulow et al., 1984; Sondergaard
et al., 1985a, b; 1993).
APC gene screening
We wished to determine whether any of our findings could be
explained on the basis of the constitutional and heterozygous
APC mutations associated with a weakly expressed form of
FAP. Hence, we searched for truncating APC mutations in all
coding sequences from exon 9 to the termination signal at the 3'
end ofexon 15, which includes all regions ofAPC known to be
associated with expression of the CHRPE phenotype in FAP
(Olschwang et al., 1993). Peripheral blood from all 33 patients
exhibiting AEM was screened by an in vitro synthesisedprotein
assay (IVSP) (Powell et al., 1993; Prosser et al., 1994) for
translation-terminating APC gene mutations and by hetero-
duplex analysis (Prosser et al., 1994; Keen et al., 1991) for each
ofexons 9- 14. Positive control samples from FAPpatients and
manufacturer's control reactions were always run in parallel.
The APC gene was amplified by polymerase chain reaction
(PCR) in overlapping fragments from DNA and RNA purified
from peripheral blood with forward PCR primers, including
signals for transcription and translation. RNA was available
for five patients in whom exons 1-14 were analysed by IVSP of
reverse-transcribed complementary DNA as described (Prosser
et al., 1994). Resultant PCR products were used in a coupled
transcription-translation reaction (Promega, UK) generating
radiolabelled synthetic polypeptide sequences, which were
analysed by SDS-PAGE followed by autoradiography.
Approximately 500 bp of the most 5' part of APC exon 15
was analysed by heteroduplex analysis in overlapping
fragments using the PCR primers as described (Groden et al.,
1991) to exclude any mutations occurring in the most 5' region
of exon 15, which would result in such a short peptide in the
IVSP assay that a mutation could be masked. Exons 9-14 were
analysed separately in all 33 patients by heteroduplex analysis
of PCR-amplified leucocyte DNA with electrophoresis on
MDETM gels (JT Baker, USA) and ethidium bromide staining
(Keen et al., 1991). Any heteroduplex variants between normal
and tumour DNA were reamplified and sequenced.
Tumour DNA instability analysis
As microsatellite DNA instability (RER phenotype) has been
observed in colorectal cancers and is the result ofinherited or of
somatic mutation in one of the DNA mismatch repair genes
(Leach et al., 1993; Parsons et al., 1993; Liu et al., 1995a;
Papadopoulos et al., 1995), we wished to correlate our findings
ofthe AEM phenotype with such tumour DNA instability. We
were able to obtain fresh surgical resection specimens form 33
ofthe patients recruited to the study at one ofthe participating
hospitals (12 with and 21 without AEMs). DNA was purified
from tumour and normal mucosa and RER status assessed by
comparison ofPCR-amplified paired tumour/control DNAs at
six PCR-amplified (CA), repeat marker loci: D2S123, D2S119,
D3S1293, D8S282, D13S160 (Gyapay et al., 1994) and at a
polyadenine tract; BAT40 (Liu et al., 1995b). Formamide-
denatured PCR products were electrophoresed on 6%
denaturing acrylamide gels in 0.5 x TBE buffer and silver-
stained (Bassam et al., 1991). All aberrant banding patterns
indicative of RER phenotype were confirmed by repeat
analyses. Tumours were considered to exhibit the RER
phenotype when band alterations were present at two or more
loci when compared with matched control DNA as described
previously (Liu et al., 1995a, b).
Results
Study group characteristics andfamily history
Cancer patients and control subjects were well age and sex
matched, although some paired control subjects did not
attend. There were 71 females and 98 male patients (mean
age 63.1 years, range 20-92 years) and 69 female and 91
male controls (mean age 62.4 years, range 32-86 years). One
hunded and fifty-one patients (89%) and 141 controls (87%)
were of Scottish descent. More patients than controls hadFamilial adenomatous polyposis and colorectal cancer
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first-degree relatives with colorectal cancer (40/169, 24% vs
16/162, 10%; P<0.003). The index case was excluded to
avoid bias in the ascertainment of HNPCC families, as, by
definition, controls cannot contribute a colorectal cancer
case. Two of the patient kindreds (1.2%) fulfilled HNPCC
criteria (Vasen et al., 1991) but none of the control families
did so. Sixteen patient (9.5%) and no control families
(P<0.0002) fulfilled more relaxed criteria for genetically
determined cases (>2 colorectal and > 1 other HNPCC
cancers in a first-degree kinship) (Mecklin, 1987; Kee and
Collins, 1991).
Prevalence of AEM in colorectal cancer patients
The prevalence of retinal and/or mandibular extracolonic
manifestations of FAP was significantly higher in patients
than in controls (33/169, 19.5% vs 12/160, 7.5%; P<0.004),
and the major contribution to this excess was retinal
pigmentation. Summary data of the proportion of each
patient group with AEMs are shown in Table I. Although we
assessed a reasonably large study population at the outset
and the differences that we observed do reach statistical
significance, it should be noted that the numbers in some of
the subcategories are small. Nonetheless, there does appear to
be an association ofAEMs with colorectal cancer and, within
the cancer group, with proximal tumour location, with an
RER phenotype and with a family history of HNPCC.
A representative case of multiple small patches of retinal
pigmentation is shown in Figure 1. Although the features
were similar to that seen in FAP, they were of lower
Table I Prevalence of extracolonic manifestations of FAP (AEMs)
in patients with sporadic colorectal cancer and in healthy control
subjects. Relationship of AEMs to patient family history of
HNPCC, tumour location and tumour RER phenotype
n Individuals with AEM
Healthy control subjects 160 12 (7.5%)
Colorectal cancer patients 169 33 (19.5%)
Right-sided tumour 53 16 (30.2%)*
Distal tumour 116 17 (14.7%)*
RER tumour phenotype 12 3 (25%)
Non-RER tumour 21 0
FHa of HNPCC 2 2 (6%)
No FHa of HNPCC 31 0
aFH family history. *P <0.05.
magnitude, being generally smaller, and there were none of
the typical large 'bear-track' lesions seen in FAP (Berk et al.,
1988; Hodgson et al., 1994). However, there was a substantial
excess of patients with retinal pigmentation, as 22/167
patients (13%) vs 8/159 control subjects (5%) had lesions
which fulfilled published diagnostic criteria for FAP patients
(Berk et al., 1988; Chapman et al., 1988; Wallis et al., 1944;
Hodgson et al., 1994) (P<0.02). Retinal pigmentation
expressed as CHRPE score for both patients and controls
is shown in Figure 2. In a sign test comparison of matched
patient/control pairs, patient CHRPE scores were signifi-
cantly greater than those of controls (Figure 2). For this
analysis, there were 160 pairs as not all control subjects
attended, and so the corresponding paired patients were
excluded. Patient scores exceeded controls in 45 and were less
than controls in 22 comparisons (P<0.01). Both patients
from HNPCC families had CHRPE, and 32% of patients
with CHRPE had a first-degree relative affected by bowel
cancer.
One of the control subjects with striking retinal
pigmentation had a father and aunt with colorectal cancer.
In the control group as a whole, in which we were able to
confirm a negative family history, CHRPE prevalence was
substantially less than in the colorectal cancer patients (4.9%
vs 19.5%, P<0.02).
Osteoma prevalence was almost 3-fold greater in patients
than in control subjects, although osteoma prevalence alone
did not reach statistical significance owing to the small
numbers. Thirteen of 163 patients (8.0%) and 5 of 159 (3%)
controls undergoing mandibular radiography had > 1
osteoma. An orthopantomogram from a patient with
colorectal cancer is shown in Figure 3.
APC gene mutation analysis
There were no constitutional truncating APC mutations
identified in peripheral blood DNA for RNA in 33 patients
with AEM (data not shown). The combination of IVSP
assays of exon 15 and heteroduplex analysis of exons 9-14
for all patients, along with IVSP analysis of cDNA for exons
1- 14 in five patients, excludes the presence of heterozygous
truncating APC mutations in those patients with extracolonic
features of FAP. Hence, unrecognised cases of FAP cannot
explain these observations.
Tumour clinicopathological characteristics
There were 172 carcinomas in 169 patients, three patients
(1.8%) having synchronous tumours. There were 14 Dukes'
Figure 1 Fundal photograph of one sector of the retina in a patient with colorectal cancer and retinal pigmentation (arrowed).
There are several small pigmented areas in this and other retinal quadrants and also a small number in the contralateral eye.Familial adenomatous polyposis and colorectal cancer
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Table II Location of 172 colorectal cancers in 169 patients and
AEM status. There were three patients with a total of two
synchronous tumours each, and these are discussed in the text
Number (%) of Number (%) of
Anatomical site tumours (n=172) patients with AEMs
Caecum 31 (18%) 6 (19.4%)
Ascending colon 15 (8.2%) 7 (46.7%)
Hepatic flexure 7 (4.1%) 3 (42.9%)
Transverse colon 10 (5.8%) 1 (10.0%)
Splenic flexure 6 (3.5%) 2 (33.3%)
Descending colon 8 (4.7%) 1 (12.5%)
Sigmoid 34 (20%) 6 (17.6%)
Rectum 61 (35.7%) 10 (16.4%)
A
N T
B
N T
C
N T
Figure 2 Plot of CHPRE scores from cases and controls
demonstrating that a significantly greater proportion of patients
had CHRPE scores > 5, corresponding to previous CHRPE
diagnostic criteria (22/167, 13% vs 8/159, 5%; P<0.02).
Figure 3 Orthopantomogram from a patient with colorectal
cancer with several radiodense regions in the body of the
mandible (arrowed).
stage A (8.1%), 85 stage B (49.4%), 73 stage C (42.5%).
There was an association between the presence of AEMs and
right-sided tumours (Table II). Right-sided tumours have also
been shown to be associated with a RER phenotype (Ionov et
al., 1993; Thibodeau et al., 1993; Lothe et al., 1993; Kim et
al., 1994). Sixteen of 53 patients (30.2%) with right (i.e.
caecal, ascending and hepatic flexure) colonic tumours had
AEMs compared with 17 of 116 patients (14.7%) with more
distal lesions (P<0.032). Interestingly, two of the patients
with synchronous tumours (66%) had AEMs while the third
had two small CHRPE lesions.
Tumour DNA instability and AEM
We analysed DNA from a total of 33 tumours for the
presence of genetic instability, 12 from patients with AEMs
and 21 from patients without AEMs. In all, three tumours
exhibited an RER phenotype, and all of these tumours were
from patients with AEMs. Thus, three tumours from the 12
patients (25%) and none from the 21 patients without AEMs
were RER tumours (P<0.05). Representative silver-stained
gels demonstrating the RER phenotype at the marker locus
D13S160 in three of the four tumours are shown in Figure 4.
Although we did not consider band shifts at only one locus
to be diagnostic of RER phenotype, four of the seven
patients (57%) with tumours exhibiting RER at > 1 locus
had AEMs, and the tumour was proximal in all of these
cases.
Figure 4 Representative silver-stained amplification products
after acrylamide gel electrophoresis for the marker D13S160
from tumour and normal mucosa DNA from four patients.
Novel, tumour specific bands are present in tumours A, B and D
indicating tumour DNA instability. In tumour A there has been a
contraction from normal in the repeat DNA at the D13S160
locus, whereas in tumour B there has been an expansion. Tumour
and normal are identical at the D13S160 locus in patient C.
Discussion
The results of this case-control study establish the
association between colorectal cancer and extracolonic
features normally associated with the autosomal dominant
syndrome of FAP. Our observations support and extend
previous reports that have noted extracolonic manifestations
of FAP in patients with colorectal cancer (Sondergaard et al.,
1985a; 1993; Houlston et al., 1992; Hunt et al., 1994). An
association between sporadic colorectal cancer and mandib-
ular osteomas has been reported in Scandinavia (Sondergaard
et al., 1985a; b; 1993), and an excess of CHRPE in selected
patients with familial non-polyposis colorectal cancer has
been reported in the UK (Houlston et al., 1992; Hunt et al.,
1994). Our findings accord well with UK study of Hunt et al.
(1994), in which a lower patient prevalence of mandibular
osteomas than that reported in Scandinavia (Sondergaard et
al., 1985a; 1993) was observed. These population differences
may indicate the involvement of environmental factors. In a
recent study by the same Scandinavian authors, there was no
evidence of an excess of CHRPE in a small cohort of 34
colorectal cancer patients (Hartvigsen et al., 1995). However,
patients with a family history of colorectal cancer were
specifically excluded from that study and so comparison with
our findings is not possible. Nonetheless, taken together,
these observations have substantial clinical relevance and
suggest that currently healthy individuals with retinal
pigmentation or craniofacial osteomas typical of AEMs
may be at increased risk of colorectal cancer. Further
studies are required to determine if the controls in. this
study who had evidence of AEMs have a higher than
expected incidence of colorectal neoplasia.
The first of two lines of investigation that we pursued, to
elucidate the molecular basis of the observed excess of AEM
20
15
10
a1)
o
0
ci,
I UL
5
0
* 0@ 0
* *0O
- f
- 1 15 116 ~
Patient Control
D
N T
^ I 25
.
*-
*-Lin colorectal cancer patients, was to exclude the presence of
constitutional APC gene mutations, as some cases might be
due to unrecognised FAP. We excluded such heterozygous
APC mutations as far as is reasonably practical in all cancer
patients with AEMs. APC mutations associated with
expression of the CHRPE phenotype in FAP patients are
restricted to a segment downstream of exon 8 (Olschwang et
al., 1993). We employed sensitive mutation detection
techniques to carry out a detailed analysis of this entire
region in blood leucocyte DNA or RNA from all patients
exhibiting the AEM phenotype (Powell et al., 1993; Prosser et
al., 1994). Constitutional APC gene defects upstream of
intron 4 can induce an attenuated FAP phenotype with very
few polyps and the late onset of cancer (Spirio et al., 1993).
Although mutations in exons 1-4 could be responsible for
some cases of apparently sporadic colorectal cancer, CHRPE
is never present in FAP cases with such mutations
(Olschwang et al., 1993) and so cannot explain our
findings. Another explanation that seems improbable
concerns the possibility that constitutional APC mutations
resulting only in amino acid alterations could be responsible
for both AEM and colorectal cancer susceptibility. However,
mutations resulting in protein truncation or in substantial
reduction in intracellular APC protein concentration is an
absolute requirement for the development of FAP (Nagase
and Nakamura, 1993; Powell et al., 1993). In addition,
truncating mutations are found almost universally in sporadic
colorectal carcinomas (Nagase and Nakamura, 1993; Powell
et al., 1992), adenomas (Powell et al., 1992; Ichii et al., 1993)
and even in some aberrant crypt foci (Jen et al., 1994; Smith
et al., 1994). This argues strongly that mis-sense APC
mutations are not responsible for our findings of an
association of colorectal neoplasia and AEMs.
Next, we determined the proportion of patients with
AEMs that exhibited genetic instability, as mutations in
mono- and dinucleotide anonymous repeat sequence muta-
tions have been observed in normal tissues in a subset of
HNPCC patients with a tumour RER phenotype (Parsons et
al., 1995). Although the numbers of cases in some of the
subcategories were small, we did observe a statistically
significant association between AEMs and a family history
of HNPCC, a proximal tumour preponderance and tumour
DNA instability, all of which are very suggestive of the
involvement of defective DNA mismatch repair. The fact that
not all patients with AEMs had a tumour with the RER
phenotype may be due to failure of our RER assay to
identify subtle DNA repair defects resulting from particular
mutations in the known MMR genes hMSH2, hMLHI,
hPMSJ and hPMS2. It is also possible that defects within
other genes known to participate in DNA mismatch repair
may induce a weak, constitutional mutator phenotype. One
such obvious candidate is GTBP, for which no germline
mutations have been found in large classical HNPCC families
(Papadopoulos et al., 1995), but low-penetrance mutations in
GTBP may be responsible for a proportion of apparently
sporadic colorectal cancer. Several other genes homologous
with the known MMR genes are also currently under
investigation by a number of research groups. Such genes
may result in a low level of genetic instability, which could
explain the lack of tumour RER phenotype in all patients
with AEMs.
There is already evidence to support the notion that
defective DNA mismatch repair can result in a constitutional
mutator phenotype and that such a phenotype results in
predisposition to cancer. Genetic instability has been
observed in normal tissue and sperm from transgenic mice
with homozygous inactivation of MLHJ and MSH2 (de
Wind et al., 1995; Baker et al., 1995). The constitutional
mutator phenotype that has been observed in HNPCC
patients with only a heterozygous MMR gene mutation
(Parsons et al., 1995) suggests that, in some cases, a
dominant-negative effect may be involved. These previous
studies set the precedent that MMR deficiency could induce
somatic mutational mosaicism at simple repeat arrays. We
Familial adenomatous polyposis and colorectal cancer
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suggest that such somatic mosaicism could also involve
mutation at the APC gene. Such mutational mosaicism would
be expected to be associated with an elevated colorectal
cancer risk in addition to the occurence of other features of
FAP, albeit less frequently and to a lesser degree than in true
FAP cases. Thus, we propose that the association of AEM
and DNA instability reported here is best explained on the
basis of APC mutations occurring in a small proportion of all
normal somatic cells, including cells contributing to colorectal
mucosa, retinal pigment epithelium and osseous tissue. This
explanation invokes the notion ofAPC mutational mosaicism
induced by DNA instability.
Further support for a link between extracolonic features of
FAP and susceptibility to colorectal cancer mediated by
genetic instability comes from three different sources. One
descriptive report documents a family in which several family
members were affected by colorectal cancer (Maher et al.,
1992). In this family, there were also a number of relatives
with fibrous tumours typical of desmoid disease, a feature
well described in classical FAP and affecting 5-7% of
polyposis patients. Further supporting evidence concerns the
association of brain tumours with colonic polyposis in
Turcot's syndrome. The genetic basis of Turcot's syndrome
in most cases is germline APC mutation, identical to the
mutations seen in classical FAP (Hamilton et al., 1995).
However, in a minority of cases, germline mutation of a
mismatch repair gene, not APC, is responsible, and this is
accompanied by a RER tumour phenotype. Finally, it is now
clear that the RER phenotype does have an important
influence from the very earliest stages of neoplastic
transformation in the colorectum. Our own recent findings
indicate that genetic instability has a marked influence on the
occurrence of APC mutations during neoplastic transforma-
tion in the colorectal epithelium (Huang et al., 1996). In that
study, we found that simple repeats within the APC gene,
especially poly-A-tracts, appear to be particular targets for
replication slippage mutations in tissues that are defective in
MMR. Thus normal tissues, including the germline, in
patients with relative MMR deficiency might also acquire
mutations in the APC gene. Somatic mutational mosaicism
has been observed in rare cases in other heritable cancer
syndromes, including Li-Fraumeni syndrome (Kovar et al.,
1992), retinoblastoma (Greger et al., 1990) and Wilms'
tumour (Chao et al., 1993).
Mosaicism may explain why the retinal and mandibular
changes that we observed in this study group were more
subtle that those seen in FAP patients. Despite every cell
carrying a mutant APC alllele in FAP patients, only a small
proportion of cells contribute to retinal and osseous lesions.
Indeed, even in the colorectum, there are some normal cells;
and some FAP patients have relatively few colonic adenomas.
Our proposed model implies that only a small proportion of
retinal and mandibular cells carry a mutant APC allele, and
so the number and extent of the retinal, osseous and indeed
colorectal lesions would be expected to be proportionately
less. Such mosaicism could represent a mechanism by which
mutations in expressed genes involved in cancer development
could accumulate in stem cells in adult, or even in
intrauterine, life without a requirement for induction of
clonal expansion. Thus, the degree of mandibular and retinal
changes would be indicative of the level of mosaicism and
perhaps even cancer risk. It is intriguing that two of the three
patients with synchronous tumours had AEM while the third
also had two small CHRPE lesions. Definitive proof of
somatic APC mosaicism in patients with AEM will require
further extensive detailed molecular analysis.
Although we favour APC mutational mosaicism as the
best interpretation of our findings, other possible hypotheses
should be considered. The features noted here could represent
phenocopies of FAP manifestations or be due to constitu-
tional down-regulation of APC by a modifier gene such as
Mom I (Dietrich et al., 1993). However, these interpretations
do not addresss our observations of a familial tendency, the
greater proportion of patients with right-sided tumoursFamilial adenomatous polyposis and colorectal cancer
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exhibiting AEMs and the association of AEM with tumour
DNA instability. The strong family history of colorectal
cancer in a control subject with marked retinal pigmentation
is also suggestive of a real association between AEM and
familial cancer susceptibility.
In conclusion, we have demonstrated an excess of
extracolonic features of FAP in an unselected patient group
with colorectal cancer but without the colonic polyposis
characteristic of FAP or a constitutional mutation in one
allele of the APC gene. Although the relationship is not
exclusive, the AEM phenotype does appear to be linked with
proximal tumour location, the RER tumour phenotype and
with a family history of HNPCC, all of which are known to
be associated with defective DNA mismatch repair. Further
studies are required to investigate these novel observations
and to elucidate this potential role for MMR deficiency in
cancer predisposition. In addition, follow-up of healthy
individuals found to have AEM in ths study may determine
whether there is indeed an associated increase in colorectal
cancer risk and whether the presence of AEM merits
colonoscopic surveillance.
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